Limula Biotech’s vision is to bring ex vivo gene-engineered cell therapies to the people. To fulfill this ambition, we offer a system that allows to automatically manufacture, from a patient white blood cell sample, genetically engineered cells at its bedside. In order to cover the production diversity of these therapies we propose a solution that can incorporate custom processes, multiple cell types and gene delivery systems.